Abbott Laboratories (ABT)
129.99 x 1 132.00 x 1
Post-market by (Cboe BZX)
130.82 -0.53 (-0.40%) 03/28/25 [NYSE]
129.99 x 1 132.00 x 1
Post-market 131.97 +1.15 (+0.88%) 17:04 ET
for Fri, Mar 28th, 2025
Try Excel 
Watch
-
Add or delete the symbol from one or more Watchlists.
-
Create New Watchlist
This name already in use.
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2024 | 12-2023 | 12-2022 | 12-2021 | 12-2020 | |
| Sales | 41,950,000 | 40,109,000 | 43,653,000 | 43,075,000 | 34,608,000 |
| Cost of Goods | 18,706,000 | 17,975,000 | 19,142,000 | 18,537,000 | 15,003,000 |
| Gross Profit | 23,244,000 | 22,134,000 | 24,511,000 | 24,538,000 | 19,605,000 |
| Operating Expenses | 16,419,000 | 15,656,000 | 16,149,000 | 16,113,000 | 14,248,000 |
| Operating Income | 6,825,000 | 6,478,000 | 8,362,000 | 8,425,000 | 5,357,000 |
| Interest Expense | 559,000 | 637,000 | 558,000 | 533,000 | 546,000 |
| Other Income | 747,000 | 823,000 | 502,000 | 319,000 | 157,000 |
| Pre-tax Income | 7,013,000 | 6,664,000 | 8,306,000 | 8,211,000 | 4,968,000 |
| Income Tax | -6,389,000 | 941,000 | 1,373,000 | 1,140,000 | 497,000 |
| Net Income Continuous | 13,402,000 | 5,723,000 | 6,933,000 | 7,071,000 | 4,471,000 |
| Net Income Discontinuous | N/A | N/A | N/A | N/A | 24,000 |
| Net Income | $13,402,000 | $5,723,000 | $6,933,000 | $7,071,000 | $4,495,000 |
| EPS Basic Total Ops | 7.67 | 3.28 | 3.94 | 3.97 | 2.52 |
| EPS Basic Continuous Ops | 7.70 | 3.29 | 3.95 | 3.98 | 2.51 |
| EPS Basic Discontinuous Ops | N/A | N/A | N/A | N/A | 0.01 |
| EPS Diluted Total Ops | 7.64 | 3.26 | 3.91 | 3.94 | 2.50 |
| EPS Diluted Continuous Ops | 7.67 | 3.27 | 3.93 | 3.95 | 2.49 |
| EPS Diluted Discontinuous Ops | N/A | N/A | N/A | N/A | 0.01 |
| EPS Diluted Before Non-Recurring Items | 4.67 | 4.44 | 5.34 | 5.21 | 3.65 |
| EBITDA(a) | $10,043,000 | $9,721,000 | $11,629,000 | $11,963,000 | $8,684,000 |